(Total Views: 197)
Posted On: 01/18/2017 8:13:39 AM
Post# of 72440
Re: thefamilyman #30572
Reputation is very subjective. Did these Mako articles damage CTIX's reputation in the eyes of Pfizer, Celgene and other BPs? CTIX doesn't sell products and convincing a judge that BPs put much weight in SA articles is tough.
It varies from venue to venue but it appears to be a moot point. I still await a piece of case law which sets a stronger precedent than NNVC vs SA. Similar company, same writer (we think), same formula and same Seeking Alpha just two years ago. I believe that even if the SEC asked for a subpoena the presiding judge would review that case and have to throw it out.
It varies from venue to venue but it appears to be a moot point. I still await a piece of case law which sets a stronger precedent than NNVC vs SA. Similar company, same writer (we think), same formula and same Seeking Alpha just two years ago. I believe that even if the SEC asked for a subpoena the presiding judge would review that case and have to throw it out.
(0)
(0)
All content of my posts is my opinion and speculation. Do not treat anything I say as fact or actionable investment advice. I participate to challenge my investment thesis from any angle possible. Please do your own due diligence.
Current Positions:
Long CTIX.
Current Positions:
Long CTIX.
Scroll down for more posts ▼
